American Herbal Products Association (AHPA) > News > Alerts

AHPA Alerts

AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.

Subscribe >>

View recent alerts:

Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.

Recent News

New U.S. tariffs proposed on Chinese imports of many herb and supplement ingredients

Proposal would increase tariffs on flax, hemp seed, ginseng, mushrooms, fish oils, minerals, and more

The U.S. Trade Representative (USTR) is proposing an additional 10 percent ad valorem duty on numerous Chinese imports with an annual trade value of approximately $200 billion. The list of products of China identified by USTR as subject to this new proposed tariff includes many herbal and plant-derived substances as well as a number of other ingredients found in dietary supplements.
AHPA submits GMO labeling recommendations to USDA

AHPA submits GMO labeling recommendations to USDA

USDA proposal would hinder consumer access to information on genetically modified foods

In an effort to ensure American consumers can discern if their food includes GMOs, AHPA recommended significant revisions to a proposed rule issued by USDA's Agricultural Marketing Service (AMS) to establish a mandatory, national bioengineered (BE) food disclosure standard.

AHPA represents member interests at Cosmetic Ingredient Review meeting

AHPA represents member interests at Cosmetic Ingredient Review meeting

AHPA attends Cosmetic Ingredient Review meeting finalizing Ginkgo biloba and eucalyptus cosmetic ingredient safety reports

American Herbal Products Association (AHPA) Chief Information Analyst Merle Zimmermann, Ph.D., attended the 147th Cosmetic Ingredient Review (CIR) Expert Panel Meeting on the safety of ingredients used in cosmetics held in Washington, D.C., Jun. 4-5. The meeting included discussions of two CIR safety reports being developed on Gingko biloba and eucalyptus cosmetic ingredients.
AHPA Presents at Canna West 2018

AHPA Presents at Canna West 2018

AHPA Chief Science Officer Dr. Johnson highlights AHPA resources for the cannabis industry

AHPA Chief Science Officer Holly Johnson, Ph.D., participated in a panel discussion yesterday on testing and labeling standards for cannabis products to increase product safety and decrease producers’ liability at Canna West 2018 held in Los Angeles.
AHPA recommends oshá harvest permitting in GMUG National Forests

AHPA recommends oshá harvest permitting in GMUG National Forests

Research supported by the AHPA ERB Foundation concludes plants have a high capacity for post‐harvest recolonization

AHPA recently submitted comments to the Grand Mesa, Uncompahgre and Gunnison (GMUG) National Forests to recommend that a revision of its plan for land and resource management include a process for permitting commercial harvest of oshá (Ligusticum porteri) root.

A Primer on AHPA’s Good Agricultural and Collection Practices and Good Manufacturing Practices (GACP-GMP) Guidance for Botanical Materials

What is AHPA's GACP-GMP guidance and how can it help your business?

Recorded May 22, 2018 -- Member cost: $150. Nonmember cost: $350.

AHPA endorses the Hemp Farming Act of 2018

AHPA Board adopts policy to support any state or federal efforts to decriminalize hemp

AHPA is endorsing federal legislation recently introduced to decriminalize hemp and the AHPA Board of Trustees has adopted a policy for the association to support any future state or federal legislation to decriminalize the plant and all its derivatives.

IADSA update on international supplement regulations

IADSA April 2018 Newsflash

This issue of the IADSA Newsflash includes an update on EFSA's proposed limit of 800 mg/day for the intake of green tea catechins in food supplements

AHPA President Michael McGuffin urges companies selling kratom to comply with all applicable laws and regulations

Statement delivered during press conference

AHPA President Michael McGuffin stressed that any company looking to sell kratom or kratom products must comply with all applicable laws and regulations during a press conference.

AHPA recommends CBD not be scheduled under any international drug control convention

AHPA submits comments to FDA to inform participation in WHO Expert Committee on Drug Dependence

AHPA submitted comments to the Food and Drug Administration (FDA) yesterday to stress that cannabidiol (CBD) requires no international drug scheduling as an individual substance and encourage the U.S. to support this position.
RSS
12345678910 Last

 Looking for Something?

 Click on these links to see a filtered list of alerts in one of these four topic areas

 

 

2018 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.